Pfizer recently announced that it pledged $100 million to the Antimicrobial Resistance (AMR) Action Fund to address the vital public health need for new antibiotics due to the rapid rise of...
HHS and the Department of Defense (DoD) recently announced a $1.6 billion agreement with Novavax Inc. to demonstrate commercial-sale manufacturing of the company’s COVID-19 investigational...
Sanofi and Regeneron Pharmaceuticals recently announced that the US Phase 3 COVID-19 clinical trial of Kevzara in patients requiring mechanical ventilation did not meet its primary and key secondary...
After an ongoing battle, the United States Court of Appeals for the Federal Circuit recently held in Amgen's favor on the validity of two patents that describe and claim Enbrel (etanercept)...
Pfizer and BioNTech recently announced positive preliminary data from an ongoing Phase 1/2 study of the most advanced COVID-19 vaccine candidate in their BNT162 mRNA-based vaccine program.
For more...
Pharmaceutical companies significantly increased drug costs for 245 drugs between January 20 and June 20, with more than 75 percent of the drugs impacted directly pertaining to COVID-19, according to a...
FDA recently announced that GSK Consumer Healthcare voluntarily recalled two lots of Children’s Robitussin and one lot of Children’s Dimetapp due to the inclusion of incorrect dosing...
AbbVie and Genmab recently signed a broad collaboration agreement to jointly develop and commercialize Genmab’s three early-stage investigational antibody therapeutics for cancer.
Genmab...
New real-world data recently showed that Trulicity had significantly higher patient adherence and longer persistence compared to weekly injections of semaglutide or exenatide in individuals with type 2...
Medicaid spent an estimated $761 million in excess costs over seven years due to delayed generic drug entry costs, according to a recent study.
Delayed generic drug entry is common,...
Bristol Myers Squibb recently announced that Zeposia (ozanimod) 0.92 mg for the treatment of relapsing multiple sclerosis (MS) is now commercially available in the US.
Ozanimod, developed by...
Women who obtained direct contraceptive prescriptions from their pharmacist were able to minimize breaks in contraceptive coverage, while increasing their continuous adherence, according to researchers...
Office of the Assistant Secretary for Preparedness and Response (ASPR) at HHS recently announced the allocation plan for remdesivir, a COVID-19 treatment for hospitalized patients.
For more...
Long-term buprenorphine treatment was linked to significantly lower rates of prescription opioid use and opioid-related events, including medically treated overdoses, according to a study from Columbia...
Using two different alternative pricing models, the Institute for Clinical and Economic Review (ICER) determined that the price for remdesivir could range from $10 to over $4,000.
For more coronavirus...
GSK recently announced that the FDA approved its PARP inhibitor monotherapy maintenance treatment for women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in...
Premier Inc recently found that drug shortages to treat cardiovascular conditions have increased due to the COVID-19 pandemic, according to a press release.
For more coronavirus updates, visit...
Merck estimates that the novel coronavirus outbreak will decrease the company’s 2020 revenues by over $2 billion as social distancing and other precautions impact business, according to the...
Two-thirds of US adults reported that prescription drug prices have increased either “a little” or “a lot” since 2017, the first year of the Trump administration, according to a...
Sanofi recently announced that FDA approved a biologics license application for a MenQuadfi meningococcal (Groups A, C, Y, W) conjugate vaccine for the prevention of meningitis in individuals two...
